CD4 and cancer: Among the 28 immune scores, there is no significant difference in the activity of CD8+ T cells and CD4+ T cells between high-risk and low-risk patients, indicating that CD8+ T cells and CD4+ T cells remain largely inactivated in the cancer immune microenvironment.